Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort

Lupus

Volumn 23, Issue 2, 2014, Pages 159-165

  Vandepapeliere J ^a   Aydin, S ^a   Cosyns, J P ^a   Depresseux, G ^a,b   Jadoul, M ^a,c   Houssiau, F A ^a,b  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b Cliniques Universitaires Saint Luc ^*  (Belgium)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

classification; Lupus nephritis; outcome; pathology; subsets

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; SERUM ALBUMIN;

ADULT; ARTICLE; CREATININE BLOOD LEVEL; DISEASE CLASSIFICATION; END STAGE RENAL DISEASE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY BIOPSY; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROLIFERATIVE LUPUS NEPHRITIS; PROTEINURIA; RENAL SYSTEM PARAMETERS; SURVIVAL;

CLASSIFICATION; LUPUS NEPHRITIS; OUTCOME; PATHOLOGY; SUBSETS;

ADULT; BELGIUM; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; LUPUS NEPHRITIS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; PROTEINURIA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84892562971     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203313514623     Document Type: Article

References (26)

1. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus. Medicine (Baltimore). 1999 ; 78: 167-175
2. Weening JJ, D'Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revisited. J Am Soc Nephrol. 2004 ; 15: 241-250
3. McCluskey RT Kidney pathology decennial 1966-1975. Sommers SC, ed. East Norwalk, CT: Appleton-Century-Crofts ; 1975: 435-450.
4. Churg J, Sobin LH Renal disease: Classification and atlas of glomerular disease. Tokyo: Igaku-Shoin ; 1982 :
5. Churg J, Bernstein J, Glassock RJ Renal disease: Classification and atlas of glomerular diseases. 2 nd ed. New York: Igaky-Shoin, 1995. New York: Igaky-Shoin ; 1995 :
6. Najafi CC, Korbet SM, Lewis EJ, et al. Significance of histologic patterns of glomerular injury upon long-term prognosis in severe lupus glomerulonephritis. Kidney Int. 2001 ; 59: 2156-2163
7. Yokoyama H, Wada T, Hara A, et al. The outcome and a new ISN/RPS 2003 classification of lupus nephritis in Japanese. Kidney Int. 2004 ; 66: 2382-2388
8. Mittal B, Hurwitz S, Rennke H, Singh AK. New subcategories of class IV lupus nephritis: Are there clinical histologic, and outcome differences?. Am J Kidney Dis. 2004 ; 44: 1050-1059
9. Hill GS, Delahousse M, Nochy D, Bariéty J. Class IV-S versus class IV-G lupus nephritis: Clinical and morphologic differences suggesting different pathogenesis. Kidney Int. 2005 ; 68: 2288-2297
10. Grootscholten C, Bajema IM, Florquin S, et al. Interobserver agreement of scoring of histopathological characteristics and classification of lupus nephritis. Nephrol Dial Transplant. 2008 ; 23: 223-230
11. Hiramatsu N, Kuroiwa T, Ikeuchi H, et al. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions. Rheumatology (Oxford). 2008 ; 47: 702-707
12. Kim YG, Kim HW, Cho YM, et al. The difference between lupus nephritis class IV-G and IV-S in Koreans: Focus on the response to cyclophosphamide induction treatment. Rheumatology (Oxford). 2008 ; 47: 311-314
13. Schwartz MM, Korbet SM, Lewis EJ. The prognosis and pathogenesis of severe lupus glomerulonephritis. Nephrol Dial Transplant. 2008 ; 23: 1298-1306
14. Kojo S, Sada K, Kobayashi M, et al. Clinical usefulness of a prognostic score in histological analysis of renal biopsy in patients with lupus nephritis. J Rheumatol. 2009 ; 36: 2218-2223
15. Yu F, Tan Y, Wu LH, Zhu SN, Liu G, Zhao MH. Class IV-G and IV-S lupus nephritis in Chinese patients: A large cohort study from a single center. Lupus. 2009 ; 18: 1073-1081
16. Haring CM, Rietveld A, van den Brand JA, Berden JH. Segmental and global subclasses of class IV lupus nephritis have similar renal outcomes. J Am Soc Nephrol. 2012 ; 23: 149-154
17. Houssiau FA, Vasconcelos C, D'Cruz D, et al. Immunosuppressive therapy in lupus nephritis: The Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide. Arthritis Rheum. 2002 ; 46: 2121-2131
18. Houssiau FA, Vasconcelos C, D'Cruz D, et al. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: Lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial. Arthritis Rheum. 2004 ; 50: 3934-3940
19. Houssiau FA, Vasconcelos C, D'Cruz D, et al. The 10-year follow-up data of the Euro-Lupus Nephritis Trial comparing low-dose and high-dose intravenous cyclosphosphamide. Ann Rheum Dis. 2010 ; 69: 61-64
20. Morel-Maroger L, Méry JP, Droz D, et al. The course of lupus nephritis: Contribution of serial renal biopsies. Adv Nephrol Necker Hosp. 1976 ; 6: 79-118
21. Korbet SM, Lewis EJ, Schwartz MM, Reichlin M, Evans J, Rohde RD. Factors predictive of outcome in severe lupus nephritis. Lupus Nephritis Collaborative Study Group. Am J Kidney Dis. 2000 ; 35: 904-914
22. Austin HA, Muenz LR, Joyce KM, et al. Prognostic factors in lupus nephritis. Contribution of renal histologic data. Am J Med. 1983 ; 75: 382-391
23. Schwartz MM, Bernstein J, Hill GS, Holley K, Phillips EA. Predictive value of renal pathology in diffuse proliferative lupus glomerulonephritis. Lupus Nephritis Collaborative Study Group. Kidney Int. 1989 ; 36: 891-896
24. Lewis EJ, Hunsicker LG, Lan SP, Rohde RD, Lachin JM. A controlled trial of plasmapheresis therapy in severe lupus nephritis. The Lupus Nephritis Collaborative Study Group. N Engl J Med. 1992 ; 326: 1373-1379
25. Korbet SM, Lewis EJ. Severe lupus nephritis: The predictive value of a ≥50% reduction in proteinuria at 6 months. Nephrol Dial Transplant. 2013 ; 28: 2313-2318
26. Dall'Era M, Stone D, Levesque V, Cisternas M, Wofsy D. Identification of biomarkers that predict response to treatment of lupus nephritis with mycophenolate mofetil or pulse cyclophosphamide. Arthritis Care Res (Hoboken). 2011 ; 63: 351-357